| Product Code: ETC7659012 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market - Industry Life Cycle |
3.4 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market - Porter's Five Forces |
3.5 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing focus on personalized medicine and precision healthcare |
4.2.2 Rising prevalence of chronic diseases in Israel |
4.2.3 Government initiatives and support for healthcare innovation |
4.3 Market Restraints |
4.3.1 High cost associated with pharmacogenomics technology |
4.3.2 Limited awareness and understanding among healthcare professionals and patients |
4.3.3 Regulatory challenges and uncertainty in the market |
5 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market Trends |
6 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market, By Types |
6.1 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By PCR, 2021- 2031F |
6.1.4 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By In-situ Hybridization, 2021- 2031F |
6.1.5 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F |
6.1.6 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.1.7 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Neurological Disorders, 2021- 2031F |
6.2.4 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Cardiovascular Disease, 2021- 2031F |
6.2.5 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Immunological Disorders, 2021- 2031F |
6.2.6 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market Import-Export Trade Statistics |
7.1 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market Export to Major Countries |
7.2 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market Imports from Major Countries |
8 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of pharmacogenomics technology in clinical practice |
8.2 Number of research collaborations between industry and academia in the field of theranostics |
8.3 Patient outcomes and cost savings achieved through companion diagnostics implementation |
9 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market - Opportunity Assessment |
9.1 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market - Competitive Landscape |
10.1 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Israel Pharmacogenomics Technology Theranostics Companion Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here